<th id="grzca"></th>
<b id="grzca"><menuitem id="grzca"></menuitem></b>

<th id="grzca"></th>
<strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    全國服務咨詢熱線:

    18438616290

    Products產(chǎn)品中心
    首頁 > 產(chǎn)品中心 > 生化試劑 > 小分子化合物 > abs47027863GSK2110183 1047644-62-1

    GSK2110183 1047644-62-1

    簡要描述:GSK2110183 1047644-62-1
    GSK2110183 is a potent pan-AKT inhibitor that demonstrated synergy with bortezomib in preclinical models of multiple myeloma (MM).

    • 產(chǎn)品型號:abs47027863
    • 廠商性質(zhì):生產(chǎn)廠家
    • 更新時間:2026-01-05
    • 訪  問  量:696

    詳細介紹

    品牌absinCAS1047644-62-1
    分子式C18H17Cl2FN4OS純度98%
    分子量427.32貨號abs47027863
    規(guī)格2mg供貨周期現(xiàn)貨
    主要用途is a potent pan-AKT inhibitor應用領域化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

    GSK2110183 1047644-62-1

    產(chǎn)品描述
    描述

    GSK2110183 is a potent pan-AKT inhibitor that demonstrated synergy with bortezomib in preclinical models of multiple myeloma (MM).

    純度
    98%
    儲存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    別名
    Afuresertib;GSK-2110183C
    可溶性/溶解性
    DMSO : ≥ 40 mg/mL (93.61 mM)
    生物活性
    靶點
    Akt1,Akt2,Akt3
    In vitro(體外研究)
    Afuresertib inhibits the kinase activity of the E17K AKT1 mutant protein with EC50 of 0.2 nM. Afuresertib shows a concentration-dependent effect on multiple AKT substrate phosphorylation levels, including GSK3b, PRAS40, FOXO and Caspase 9. Overall 65% of the hematological cell lines are sensitive to afuresertib (EC50
    In vivo(體內(nèi)研究)
    Mice bearing BT474 breast tumor xenografts are dosed with afuresertib (p.o.) at 10, 30 or 100 mg/kg daily which results in 8, 37 and 61% TGI, respectively. Mice bearing SKOV3 ovarian tumor xenografts are treated with 10, 30 and 100 mg/kg afuresertib which results in 23, 37 and 97% TGI, respectively.
    研究領域
    研究領域
    CancerCell DeathApoptosisMetabolism
    CancerSignal transductionProtein phosphorylationSerine/threonine kinasesAKT
    EpigeneticsCell cycleApoptosisNuclear
    MetabolismPathways and ProcessesMetabolism processesApoptosis
    Signal TransductionProtein PhosphorylationSer / Thr KinasesPKB / AKT
    Drug DiscoverySmall Molecule DrugLead Compound Discovery
    GSK2110183 1047644-62-1溫馨提示:本產(chǎn)品僅作科研實驗使用,不支持臨床等研究

    產(chǎn)品咨詢

    留言框

    • 產(chǎn)品:

    • 您的單位:

    • 您的姓名:

    • 聯(lián)系電話:

    • 常用郵箱:

    • 省份:

    • 詳細地址:

    • 補充說明:

    • 驗證碼:

      請輸入計算結(jié)果(填寫阿拉伯數(shù)字),如:三加四=7
    愛必信(上海)生物科技有限公司
    地址:上海市浦東新區(qū)新浩路58號申江科創(chuàng)園18棟
    傳真:
    關注我們
    歡迎您關注我們的微信公眾號了解更多信息:
    歡迎您關注我們的微信公眾號
    了解更多信息
    <th id="grzca"></th>
    <b id="grzca"><menuitem id="grzca"></menuitem></b>

    <th id="grzca"></th>
    <strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    性爱豹妹RR一092 | 日韩城人网站 | w超清无码在线观看 | 尻屄免费视频 | 日女人逼逼 |